Piper Sandler analyst David Amsellem reiterated a Hold rating on Supernus Pharmaceuticals (SUPN – Research Report) today and set a price target ...

Piper Sandler analyst David Westenberg maintained a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $18.00.

In a report released today, Brent Bracelin from Piper Sandler maintained a Hold rating on Workday (WDAY – Research Report), with a price target ...

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Day One Biopharmaceuticals (DAWN – Research Report), ...

Piper Sandler started coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a report released on Monday, ...

Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the ...

Nvidia (NASDAQ:NVDA) is once again at the center of Wall Street's attention as analysts set the stage for another strong ...

Principal Financial Group Inc. increased its holdings in shares of First Hawaiian, Inc. (NASDAQ:FHB – Free Report) by 2.9% during the 4th quarter, according to the company in its most recent filing ...

Société Générale highlighted another strong earnings season, with nearly half of the 428 companies out of the S&P 500's ...

The vibes are shifting on Wall Street. Popular gauges of investor sentiment are showing that the pervasive sense of optimism that followed President Donald Trump’s election victory in November has ...

Piper Sandler analyst Anna Andreeva reiterated a Buy rating on Revolve Group (RVLV – Research Report) today and set a price target of $35.00.

Piper Sandler raised the firm’s price target on Intuit (INTU) to $785 from $765 and keeps an Overweight rating on the shares. The firm says ...